Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer

NCT00113334 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: ABT-510

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]